Liquid Alpha1-Proteinase Inhibitor (Human)

alpha-1 proteinase inhibitor (human) · Grifols Therapeutics LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Liquid Alpha1-Proteinase Inhibitor (Human), covering 2017-03-13 to 2023-03-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19) [Phase 2]

See pricing